Dimemorfan phosphate

磷酸二甲吗喃

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDimemorfan phosphate
Drug Alias Namedimemorfano磷酸二甲啡烷dimemorfanumAstominAT-17
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSigma opioid receptor agonists
TargetsSigma opioid receptor
Therapy Area/IndicationsCoughSilicosisLung Neoplasms +[9
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCoughSilicosisLung Neoplasms +[9
Inactive IndicationsN/A

Other Information

ATC CodeR05DA11
Related LinksWikipediaKEGG